Skipped

There was no IPPractice email update on Thursday, March 22 due to problems accessing the Federal Court website. The update for Friday contains updates for both Thursday and Friday.

Canadian Trademark Filings in 2017

About 55,000 trademark applications were filed in Canada in 2017. Of these, about 25% were filed in-house or without an agent (up slightly from previous years, and up from 17% in 2010). Check out my list of the 50 firms/agents that filed the most applications in 2017.

Top 5 trademark filers in 2017: Brandster Branding Ltd., Target Brands, The Procter & Gamble Company, Johnson & Johnson, and L’Oreal. Continue reading Canadian Trademark Filings in 2017

2017 in Review

As we come to the end 2017, here is a summary of the most popular* items from the past year. CETA and NAFTA were of the most interest with four of the top five posts relating to the Eli Lilly NAFTA arbitration decision and the implementation of changes to the PM(NOC) Regulations and geographic indicators:

Most popular reported decisions:

  • Mostar Directional Technologies Inc. v Drill-Tek Corporation et al., 2017 FC 575
  • Bombardier Recreational Products Inc. v. Arctic Cat Inc., 2017 FC 207
  • The Dow Chemical Company et al v Nova Chemicals Corporation, 2017 FC 350
  • Sleep Country Canada Inc. v. Sears Canada Inc., 2017 FC 148
  • Apotex Inc. v Eli Lilly and Company, 2017 ONSC 7204

Continue reading 2017 in Review

Season’s Greetings

As we come to the end of another year, I would like to thank all my IPPractice subscribers, currently approximately 1600. I would also like to remind you to check out your subscription preferences to take advantage of some of the features available, including:

  • new Federal Court and Federal Court proceedings;
  • intellectual property decisions;
  • monitoring developments on specific Federal Court, Federal Court of Appeal and Supreme Court of Canada proceedings;
  • newly scheduled hearings and applications in the Federal Court;
  • updates on IP cases at the Supreme Court of Canada including leave applications and decisions;
  • alerts on Copyright Board rulings and decision;
  • newly listed innovative drugs listed by Health Canada;
  • newly listed patents on Health Canada’s Patent Register;
  • CIRA domain name decisions;
  • Patent Appeal Board decisions; and
  • Trademark Opposition Board decisions.

I welcome any feature requests, bug reports, comments and financial contributions. All the best for the holidays and I look forward to connecting with many of you in 2018!

Canadian Intellectual Property